The impact of dyspepsia definition on prevalence estimates: Considerations for future researchers

Scandinavian Journal of Gastroenterology

Volumn 35, Issue 3, 2000, Pages 227-233

  Westbrook, J I ^a   McIntosh, J H ^a   Talley, N J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; CONSULTATION; DEMOGRAPHY; DYSPEPSIA; GASTROESOPHAGEAL REFLUX; HEALTH CARE COST; HEARTBURN; HUMAN; MEDICAL RESEARCH; PREVALENCE; PRIORITY JOURNAL; REVIEW;

EID: 0034006110     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655200750024065     Document Type: Review

References (66)

1. 1. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ. Smoking, alcohol, and analgesics in dyspepsia and among dyspepsia subgroups: lack of an association in a community. Gut 1994; 35:619-24.
2. 2. Penston JG, Pounder RE. A survey of dyspepsia in Great Britain. Aliment Pharmacol Ther 1996;10:83-9.
3. 3. Kay L, Jørgensen T. Epidemiology of upper dyspepsia in a random population. Prevalence, incidence, natural history, and risk factors. Scand J Gastroenterol 1994;29:1-6.
4. 4. Agreus L, Svardsudd K, Nyren O, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 1995; 109:671-80.
5. 5. Knill-Jones RP. Geographical differences in the prevalence of dyspepsia. Scand J Gastroenterol 1991;26:17-24.
6. 6. Lyons RA, Caroll D, Doherty K, Flynn M, Mason J, O'Brien D, et al. General practice estimates of the prevalence of common chronic conditions. Irish Med J 1992;85:22-4.
7. 7. Crean GP, Holden RJ, Knill-Jones RP, Beattie AD, James WB, Marjoribanks FM, et al. A database on dyspepsia. Gut 1994;35: 191-202.
8. 8. Westbrook J, Talley N, McIntosh J, Rushworth R. Prevalence of dyspepsia in NSW: a pilot survey. J Gasteroenterol Hepatol 1997;12:A103.
9. 9. Westbrook J, Talley N, McIntosh J. Dyspepsia: prevalence, subgroups and health care seeking - a random survey of 2300 households. Gastroenterology 1998;114:A.
10. 10. Stanghellini V, Tosetti C, Paternico A, Barbara G, Morselli-Labate A, Monetti N, et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 1996;110:1036-42.
11. 11. Lydeard S, Jones R. Factors affecting the decision to consult with dyspepsia: comparison of consulters and non-consulters. J R Coll Gen Pract 1989;39:495-8.
12. 12. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 1992;102:1259-68.
13. 13. Wiklund IK, Junghard O, Grace E, Talley NJ, Kamm M, Veldhuyzen van Zanten S, et al. Quality of life in reflux and dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg 1998; Suppl 583:41-9.
14. 14. Talley NJ, Haque M, Wyeth JW, Stace NH, Tytgat GNJ, Stanghellini V, et al. Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index. Aliment Pharmacol Ther 1999;13:225-35.
15. 15. Talley NJ, Weaver AL, Zinmeister AR. Impact of functional dyspepsia on quality of life. Dig Dis Sci 1995;40:584-9.
16. 16. Bytzer P, Hansen JM, Schaffalitzky de Muckadell OB. Empirical H2 blocker therapy or prompt endoscopy in management of dyspepsia. Lancet 1994;343:811-6.
17. 17. Silverstein MD, Petterson T, Talley NJ. Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis. Gastroenterology 1996;110: 72-83.
18. 18. Fisher RS, Parkman HP. Current concepts: management of nonulcer dyspepsia. N Engl J Med 1998;339:1376-81.
19. 19. Ofman JJ, Rabeneck L. The effectiveness of endoscopy in the management of dyspepsia: a qualitative systematic review. Am J Med 1999;106:335-46.
20. 20. Nyren O, Lindberg G, Lindstrom E, Marke L, Seensalu R. Economic costs of functional dyspepsia. Pharmacoeconomics 1992;1:312-24.
21. 21. Morrissey JF. Gastrointestinal endoscopy. N Engl J Med 1991; 325:1142-9.
22. 22. Ryder SD, O'Reilly S, Miller RJ, Ross J, Jacyna MR, Levi AJ. Long term acid suppressing treatment in general practice. Br Med J 1994;308:827-30.
23. 23. Nyren O, Adami H, Gustavsson S, Loof L. Excess sick-listing in nonulcer dyspepsia. Clin Gastroenterol 1986;8:339-45.
24. 24. Jones R, Lydeard S. Prevalence of symptoms of dyspepsia in the community. BMJ 1989;298:30-2.
25. 25. Tibblin G. Introduction to the epidemiology of dyspepsia. Scand J Gastroenterol 1985;20:29-33.
26. 26. Kay L. Prevalence, incidence and prognosis of gastrointestinal symptoms in a random sample of an elderly population. Age Ageing 1994;23:146-9.
27. 27. Bernersen B, Johnsen R, Straume B. Non-ulcer dyspepsia and peptic ulcer: the distribution in a population and their relation to risk factors. Gut 1996;38:822-5.
28. 28. Agreus L, Svardsudd K, Nyren O, Tibblin G. The epidemiology of abdominal symptoms: prevalence and demographic characteristics in a Swedish adult population. Scand J Gastroenterol 1994;29:102-9.
29. 29. Weir RD, Backett EM. Studies of the epidemiology of peptic ulcer in a rural community: prevalence and natural history of dyspepsia and peptic ulcer. Gut 1968;9:75-83.
30. 30. Jones RH, Lydeard SE, Hobbs FDR, Kenkre JE, Williams El, Jones SJ, et al. Dyspepsia in England and Scotland. Gut 1990;31:401-5.
31. 31. Jones R, Lydeard S. Dyspepsia in the community: a follow-up study. Br J Clin Prac 1992;46:95-7.
32. 32. Kennedy T, Jones R, Hungin A, O'Flanagan H, Kelly P. Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper-responsiveness in the general population. Gut 1998;43: 770-4.
33. 33. Talley NJ, O'Keefe EA, Zinsmeister AR, Melton LJ III. Prevalence of gastrointestinal symptoms in the elderly: a population-based study. Gastroenterology 1992;102:895-901.
34. 34. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ III. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol 1992;136:165-77.
35. 35. Talley NJ, Evans JM, Fleming KC, Harmsen WS, Zinsmeister AR, Melton LJ III. Nonsteroidal antiinflammatory drugs and dyspepsia in the elderly. Dig Dis Sci 1995;40:1345-50.
36. 36. Holtmann G, Goebell H, Talley N. Dyspepsia in consulters and non-consulters: Prevalence, health-care seeking behaviour and risk factors. Eur J Gastroenterol 1994;6:917-24.
37. 37. Talley NJ, Boyce P, Jones M. Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population. Gut 1998;42:690-5.
38. 38. Colin-Jones D. Management of dyspepsia: report of a working party. Lancet 1988;1:576-9.
39. 39. Barbara L, Camilleri M, Corinaldesi R, Crean GP, Heading RC, Johnson AG, et al. Definition and investigation of dyspepsia: consensus of an international ad hoc working party. Dig Dis Sci 1989;34:1272-6.
40. 40. Talley NJ, Colin-Jones D, Koch KL, Koch M, Nyren O, Stanghellini V. Functional dyspepsia: a classification with guidelines for diagnosis and management. Gastroenterol Int 1991;4:145-60.
41. 41. Talley N, Stanghellini V, Heading R, Kock K, Malagelada J, Tytgat G. Functional gastroduodenal disorders. Gut 1999;45 Suppl 2:1137-42.
42. 42. American College of Physicians Health and Public Policy Committee. Endoscopy in the evaluation of dyspepsia: a position paper. Ann Intern Med 1985;102:266-9.
43. 43. Heading RC. Definitions of dyspepsia. Scand J Gastroenterol 1991;26:1-6.
44. 44. Thompson W. Dyspepsia: is a trial of therapy appropriate? Can Med Assoc J 1995;153:293-9.
45. 45. Kraag N, Thijs C, Knipschild P. Dyspepsia - how noisy are gallstones? A meta-analysis of epidemiologic studies of biliary pain, dyspeptic symptoms, and food intolerance. Scand J Gastroenterol 1995;30:411-21.
46. 46. Talley NJ. Gallstones and upper abdominal discomfort. Innocent bystander or a cause of dyspepsia? [editorial]. J Clin Gastroenterol 1995;20:182-3.
47. 47. Bytzer P, Hansen JM, Havelund T, Malchow-Moller A, Schaffalitzky de Muckadell OB. Predicting endoscopic diagnosis in the dyspeptic patient: the value of clinical judgement. Eur J Gastroenterol Hepatol 1996;8:359-63.
48. 48. Richter J. Dyspepsia: organic causes and differential characteristics from functional dyspepsia. Scand J Gastroenterol 1991;26: 11-6.
49. 49. Berstad A, Hausken T, Gilja OH, Nesland A, Odegaard S. Imaging studies in dyspepsia. Eur J Surg 1998;Suppl 582:42-9.
50. 50. Camilleri M. Nonulcer dyspepsia: a look into the future. Mayo Clin Proc 1996;71:614-22.
51. 51. Carlsson R, Dent J, Bolling-Sternevald E, Johnsson F, Junghard O, Lauritsen K, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol 1998;33:1023-9.
52. 52. Veldhuyzen van Zanten S, Cleary C, Talley N, Peterson T, Nyren O, Bradley L, et al. Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol 1996;91:660-73.
53. 53. Talley N, Silverstein M, Agreus L, Nyren O, Sonnenberg A, Holtmann G. AGA technical review: evaluation of dyspepsia. Gastroenterology 1998;114:582-95.
54. 54. Kay L, Jorgensen T. Abdominal symptom associations in a longitudinal study. Int J Epidemiol 1993;22:1093-100.
55. 55. Kay L, Jorgensen T. Redefining abdominal syndromes: results of a population-based study. Scand J Gastroenterol 1996;31: 469-75.
56. 56. Whitehead W, Crowell M, Bosmajian L, Zonderman A, Costa P, Benjamin C, et al. Existence of irritable bowel syndrome supported by factor analysis of symptoms in two community samples. Gastroenterology 1990;98:336-40.
57. 57. Veldhuyzen van Zanten SJO, Tytgat KMAJ, Pollak PT, Goldie J, Goodacre RL, Riddell RH, et al. Can severity of symptoms be used as an outcome measure in trials of non-ulcer dyspepsia and Helicobacter pylori associated gastritis? J Clin Epidemiol 1993;46:273-9.
58. 58. Johannessen T, Peterson H, Kristensen P, Kleveland P, Dybdahl J, Sandvik A, et al. The intensity and variability of symptoms in dyspepsia. Scand J Prim Health Care 1993;11:50-5.
59. 59. Talley NJ, McNeil D, Hayden A, Piper DW. Randomised, double-blind, placebo-controlled crossover trial of cimetidine and pirenzepine in nonulcer dyspepsia. Gastroenterology 1986; 91:149-56.
60. 60. Lambert JR, Dunn K, Borromeo M, Korman MG, Hansky J. Campylobacter pylori - a role in non-ulcer dyspepsia? Scand J Gastroenterol 1989;24:7-13.
61. 61. Hausken T, Stene-Larsen G, Lange O, Aronsen O, Nerdrum T, Hegbom F, et al. Misoprostol treatment exacerbates abdominal discomfort in patients with non-ulcer dyspepsia and erosive prepyloric changes: a double blind, placebo-controlled, multi-centre study. Scand J Gastroenterol 1990;25:1028-33.
62. 62. Goh KL, Parasakthi N, Peh SC, Wong NW, Lo YL, Puthucheary SD. Helicobacter pylori infection and non-ulcer dyspepsia: the effect of treatment with colloidal bismuth subcitrate. Scand J Gastroenterol 1991;26:1123-31.
63. 63. Thompson WG, Heaton KW. Functional bowel disorders in apparently healthy people. Gastroenterology 1980;79:283-8.
64. 64. Villani L, Trespi E, Fiocca R, Broglia E, Colla C, Luinetti O, et al. Analysis of gastroduodenitis and oesophagitis in relation to dyspeptic/reflux symptoms. Digestion 1998;59:91-101.
65. 65. Gilvarry J, Buckley M, Beattie S, Hamilton H, O'Morain C. Eradication of Helicobacter pylori affects symptoms in non-ulcer dyspepsia. Scand J Gastroenterol 1997;32:535-40.
66. 66. El-Omar EM, Banerjee S, Wirz A, McColl KEL. The Glasgow dyspepsia severity score - a tool for the global measurement of dyspepsia. Eur J Gastroenterol Hepatol 1996;8:967-71.